The findings indicate that ZDHHC5 contributes to the pathogenesis of GAD by modulating SSC‐A on CD4+ T cells, thereby offering novel targets for the investigation of GAD pathophysiology. The gene discussed is ZDHHC5; the disease is generalized anxiety disorder.